Hepatitis C (chronic) - sofosbuvir: evaluation report

01 - Pre-Meeting Briefing prepared by NICE

02 - Submission from the technology manufacturer - Gilead Sciences

03 - Extract from the appendices to the manufacturer's submission - Gilead Sciences

04 - NICE request to the manufacturer for clarification on their submission

05 - Manufacturer clarification response

06 - Consultee submission - British HIV Association and British Association for Sexual Health and HIV

07 - Consultee submission - Hepatitis C Trust

08 - Consultee submission - Royal College of Nursing

09 - Clinical expert personal perspective - Aspinall

10 - Patient expert personal perspective - Gore

11 - Clinical expert personal perspective - Jacobs

12 - Patient expert personal perspective - Zapletal

13 - Evidence Review Group report prepared by Southampton Health Technology Assessments Centre (SHTAC)

14 - Erratum to the Evidence Review Group report prepared by Southampton Health Technology Assessments Centre (SHTAC)

15 - Manufacturer factual accuracy check of Evidence Review Group report

16 - Exploratory analyses prepared by Southampton Health Technology Assessments Centre (SHTAC)

 

Please be advised that the format of evaluation reports shared on the NICE website has recently changed, for ease of user navigation between individual documents contained in the report.

It is a requirement of the new (PDF portfolio) format that Adobe Reader is used to view the document. Please follow the link at the bottom of this page to download Adobe Reader if required.

If you have any feedback on the new format please contact the Project Manager for this appraisal.


This page was last updated: 20 June 2014